drugset / Trial / NCT00032955
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
Open-labelTreatment
Summary
The purpose of this study is to assess buprenorphine/naloxone versus clonidine for inpatient opiate detoxification.
Timeline
- Start
- 2001-02
- Primary completion
- 2002-08
- Completion
- 2002-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 16 mg | Subcutaneous |
| Subject | Naloxone | Small molecule | 4 mg | Subcutaneous |